Baxter International Inc. stock underperforms Thursday when compared to competitors
Baxter International Inc. closed 29.99% short of its 52-week high of $44.01, which the company reached on March 8th.
Baxter announces CEO’s immediate retirement, days after $3.7B sale of kidney care business
Deerfield-based Baxter International announced Monday that its CEO and board Chair José Almeida is retiring, effective ...
Baxter International: A Possible Value Trap
Despite strong revenue growth, Baxter struggles with profitability and high long-term debt. Click here to read why BAX stock ...
Baxter International Inc. CEO Transition and Financial Update
Baxter International Inc. (NYSE: BAX) has recently announced significant changes to its executive leadership and provided an update on its financial outlook through an 8-K filing with the Securities ...
Baxter International Weighing Potential Tariff Impact
Baxter International said it weighing the potential impact of the Trump administration's planned tariffs on the medical-products maker's guidance.
Baxter Kidney Care becomes Vantive following acquisition by Carlyle funds
Vantive, formerly the Baxter Kidney Care segment, launched as a new standalone vital organ therapy company following the completion of its ...
Baxter names new Senior VP and Chief Accounting Officer
DEERFIELD, IL – Baxter International Inc. (NYSE:BAX), a global leader in medical products with a market capitalization of $16 ...